A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents With Type 2 Diabetes.

Completed · Phase 3

Conditions studied: Diabetes Mellitus, Non-Insulin-Dependent

In brief

The purpose of this clinical research study is to see if Glucovance, a medication currently approved for use in adults with type 2 diabetes, can control type 2 diabetes safely and effectively in children 9 to 16 years of age.

Key facts

Study ID
NCT00035542
Run by
Bristol-Myers Squibb
Starts
2001-12-01
Expected to finish
2003-10-01
Last updated by the study team
2011-04-15

Who can join

Age: 9 and older, up to 16. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.